CIBC Asset Management Inc Acquires 49,815 Shares of GE HealthCare Technologies Inc. $GEHC

CIBC Asset Management Inc raised its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 35.5% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 190,238 shares of the company’s stock after acquiring an additional 49,815 shares during the quarter. CIBC Asset Management Inc’s holdings in GE HealthCare Technologies were worth $15,603,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Western Wealth Management LLC increased its stake in shares of GE HealthCare Technologies by 2.4% in the 4th quarter. Western Wealth Management LLC now owns 5,240 shares of the company’s stock valued at $430,000 after acquiring an additional 125 shares in the last quarter. United Community Bank boosted its stake in GE HealthCare Technologies by 10.2% during the fourth quarter. United Community Bank now owns 1,410 shares of the company’s stock worth $116,000 after acquiring an additional 130 shares in the last quarter. Thoma Capital Management LLC grew its holdings in GE HealthCare Technologies by 1.4% in the fourth quarter. Thoma Capital Management LLC now owns 9,918 shares of the company’s stock worth $814,000 after purchasing an additional 136 shares during the period. Colonial Trust Advisors grew its holdings in GE HealthCare Technologies by 11.1% in the third quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock worth $104,000 after purchasing an additional 139 shares during the period. Finally, Norinchukin Bank The increased its stake in GE HealthCare Technologies by 0.4% in the third quarter. Norinchukin Bank The now owns 38,913 shares of the company’s stock valued at $2,922,000 after purchasing an additional 149 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.

Insider Buying and Selling at GE HealthCare Technologies

In other news, Director Kevin Lobo purchased 10,000 shares of the company’s stock in a transaction that occurred on Friday, May 22nd. The shares were bought at an average cost of $64.18 per share, with a total value of $641,800.00. Following the completion of the transaction, the director directly owned 14,363 shares of the company’s stock, valued at approximately $921,817.34. This trade represents a 229.20% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Watkin Phoebe L. Yang purchased 1,000 shares of the business’s stock in a transaction that occurred on Friday, May 8th. The shares were purchased at an average price of $63.01 per share, for a total transaction of $63,010.00. Following the completion of the acquisition, the director owned 13,702 shares of the company’s stock, valued at $863,363.02. The trade was a 7.87% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased a total of 21,847 shares of company stock valued at $1,361,355 in the last three months. Insiders own 0.36% of the company’s stock.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $63.81 on Friday. The stock has a market cap of $29.03 billion, a price-to-earnings ratio of 15.27, a PEG ratio of 1.40 and a beta of 0.74. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. GE HealthCare Technologies Inc. has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The firm’s 50-day simple moving average is $67.04 and its 200 day simple moving average is $75.56.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The company had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.04 billion. During the same period last year, the company earned $1.01 earnings per share. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on GEHC shares. Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, March 21st. BTIG Research decreased their target price on GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating for the company in a research report on Wednesday, April 29th. HSBC cut their price target on GE HealthCare Technologies from $100.00 to $90.00 in a report on Thursday, April 30th. Wells Fargo & Company reduced their price objective on GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a research note on Thursday, April 30th. Finally, Stifel Nicolaus set a $80.00 price objective on GE HealthCare Technologies in a report on Wednesday, April 29th. Nine investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and an average target price of $80.21.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.